Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Liabilities and Shareholders Equity (2020 - 2025)

GeneDx Holdings has reported Liabilities and Shareholders Equity over the past 6 years, most recently at $523.7 million for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $523.7 million for Q4 2025, up 24.88% from a year ago — trailing twelve months through Dec 2025 was $1.9 billion (up 19.61% YoY), and the annual figure for FY2025 was $523.7 million, up 24.88%.
  • Liabilities and Shareholders Equity for Q4 2025 was $523.7 million at GeneDx Holdings, up from $493.9 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for WGSWW hit a ceiling of $933.3 million in Q2 2022 and a floor of $175.5 million in Q2 2021.
  • Median Liabilities and Shareholders Equity over the past 5 years was $470.1 million (2023), compared with a mean of $486.0 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: soared 431.68% in 2022 and later crashed 49.66% in 2023.
  • GeneDx Holdings' Liabilities and Shareholders Equity stood at $554.1 million in 2021, then decreased by 11.4% to $490.9 million in 2022, then dropped by 14.7% to $418.8 million in 2023, then grew by 0.15% to $419.4 million in 2024, then increased by 24.88% to $523.7 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $523.7 million (Q4 2025), $493.9 million (Q3 2025), and $463.9 million (Q2 2025) per Business Quant data.